FDA inspection
Biomat USA, Inc.: FDA inspection ending Aug 14, 2017
FDA inspection 1023216 · No Action Indicated (NAI) · Indianapolis, IN
Key facts
| Inspection ID | 1023216 |
|---|---|
| Firm | Biomat USA, Inc. |
| FEI number | 1876557 |
| Address | 502 N Capitol Ave |
| City | Indianapolis |
| State | IN |
| ZIP | 46204 |
| Country | United States |
| Fiscal year | 2017 |
| Inspection end date | Aug 14, 2017 |
| Classification | No Action Indicated (NAI) |
| Project area | Blood and Blood Products |
| Product type | Biologics |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data